Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ApaTech attracts seasoned spinal executive as VP OUS markets

This article was originally published in Clinica

Executive Summary

ApaTech (Hertfordshire, UK), a specialist in the production of synthetic bone repair material and bone graft technologies, has appointed Geert Hertecant as vice-president for all markets outside the US. The company currently supplies to 21 countries, with leading markets being the UK and Germany. Mr Hertecant joins from Medtronic, where he was regional business director for North Europe of the spine and biologics division. He is a seasoned Medtronic executive: having joined the company as business manager for the spine division, he later joined Kyphon (minimally-invasive spinal function restoration therapies) as regional business director for North Europe; when Kyphon was bought by Medtronic in 2007, Mr Hertecant continued to serve in the role at Medtronic. “Geert brings a strong track record of successfully launching new products across Europe,” said Simon Cartmell, CEO of ApaTech.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043446

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel